Metoprolol succinate and Inflammatory marker increased - a phase IV clinical study of FDA data

Summary:

Inflammatory marker increased is reported as a side effect among people who take Metoprolol succinate (metoprolol succinate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Humira, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Inflammatory marker increased when taking Metoprolol succinate. It is created by eHealthMe based on reports of 64,247 people who have side effects when taking Metoprolol succinate from the FDA, and is updated regularly.

What is Metoprolol succinate?

Metoprolol succinate has active ingredients of metoprolol succinate. It is often used in high blood pressure. eHealthMe is studying from 66,933 Metoprolol succinate users. Check the latest studies of Metoprolol succinate.

What is Inflammatory marker increased?

Inflammatory marker increased is found to be associated with 395 drugs and 391 conditions by eHealthMe. Check the latest studies of Inflammatory marker increased.

On Jul, 06, 2026

64,247 people reported to have side effects when taking Metoprolol succinate.
Among them, 44 people (0.07%) have Inflammatory marker increased.

Could Metoprolol succinate cause Inflammatory marker increased?

Among these 44 people:

How long have people been on Metoprolol succinate when they have Inflammatory marker increased? *

What is the gender of people who have Inflammatory marker increased when taking Metoprolol succinate? *

female: 78.05 %
male: 21.95 %

What is the age of people who have Inflammatory marker increased when taking Metoprolol succinate? *

What are other drugs people take besides Metoprolol succinate? *

Humira: 30 people, 68.18%
Movicol: 27 people, 61.36%
Clopidogrel: 24 people, 54.55%
Pantoprazole: 20 people, 45.45%
Fentanyl Transdermal System: 14 people, 31.82%
Folic Acid: 12 people, 27.27%
Prednisolone: 8 people, 18.18%
Voltaren: 7 people, 15.91%
Aspirin: 7 people, 15.91%
Lactulose: 7 people, 15.91%

What are other side effects people have besides Inflammatory marker increased? *

Nausea And Vomiting: 30 people, 68.18%
Aortic Arteriosclerosis (hardening of the aortic arteries): 29 people, 65.91%
Gait Disturbance: 29 people, 65.91%
Peripheral Swelling: 29 people, 65.91%
General Physical Health Deterioration (weak health status): 29 people, 65.91%
Joint Pain: 29 people, 65.91%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 28 people, 63.64%
Joint Dislocation (a joint position is changed from normal position): 27 people, 61.36%
Wound Dehiscence (a surgical incision reopens either internally or externally): 27 people, 61.36%
Impaired Healing: 27 people, 61.36%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 27 people, 61.36%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 13.64%
Malignant Melanoma (skin cancer rises from melancytes): 4 people, 9.09%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 4 people, 9.09%
Type 2 Diabetes: 4 people, 9.09%
Essential Hypertension (primary hypertension): 3 people, 6.82%
Candidiasis (candidiasis or thrush is a fungal infection): 3 people, 6.82%
Respiratory Tract Infection: 3 people, 6.82%
Rickets (softening of bones): 3 people, 6.82%
Pancreatic Neuroendocrine Tumor Metastatic: 2 people, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Metoprolol succinate and have Inflammatory marker increased?

- Check whether Inflammatory marker increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Metoprolol succinate:

Metoprolol succinate (66,933 reports)

Browse all side effects of Metoprolol succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Inflammatory marker increased:

Inflammatory marker increased (395 drugs)

Browse all the conditions that are associated with Inflammatory marker increased:

Inflammatory marker increased (391 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol succinate (the active ingredients of Metoprolol succinate) and Metoprolol succinate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.